利用人類多能胚胎幹細胞衍生之心肌細胞探討RBM24之功能

Functional Study of RNA-Binding Motif Protein 24 in Human Pluripotent Stem Cell-Derived Cardiomyocytes

張家維(Chia-Wei Chang)

指導教授 ： 蔡素宜

國立臺灣大學/生命科學院/生命科學系/碩士(2018年)

https://doi.org/10.6342/NTU201804112

摘要

心臟肌節基因的缺陷通常造成嚴重的心肌疾病，而目前大多數治療心臟衰竭的方法無法根治肌肉缺陷的問題。RBM24被視作為調節心臟發育及肌節發育過程中，調控mRNA拼接的重要角色。然而，RBM24中具有主要功能的區域及其在人類心肌細胞發育過程中詳細的功能仍未被證實。本研究在人類胚胎幹細胞中利用CRISPR/Cas9系統分別剔除RBM24基因之兩個不同區域，以測試RBM24之RRM 結構域的功能。在此結果中，兩種剔除細胞株之心肌細胞雖然可以正常跳動，但剔除RRM結構域之細胞株之心肌細胞呈現肌節構造排列不規則及不正常之粒線體表現型。對比之下，於Exon2剔除細胞株在肌節構造、心肌細胞大小及粒線體形態上均呈正常表現型。整體而言，本研究不只初步證明了RBM24之RRM結構域在人類胚胎幹細胞衍生之心肌肌節生成中扮演必要角色，並更進一步發現RBM24蛋白可能影響心肌細胞中粒線體之功能。未來我將利用RNA sequencing的方法，去更進一步了解RRM結構域之功能在心肌肌節生成的分子機制。

關鍵字

人類全能幹細胞 ； RNA結合模組蛋白24 ； RRM結構域 ； 心肌細胞 ； 肌節生成 ； 心臟性分化 ； CRISPR/Cas9系統

並列摘要

The abnormal expression of cardiac sarcomere genes usually results in cardiomyopathy. However, current treatments for heart failure do not address the root problem involving cardiac muscle deficiencies. RNA-binding motif protein 24 (RBM24) is a key regulator of the alternative splicing of mRNA during cardiomyogenesis and sarcomerogenesis. The functional region of RBM24 that mediates cardiac development in humans remains to be elucidated. In this thesis project, I used human embryonic stem cells (hESCs) as a model system and eliminated two RBM24 regions using the CRISPR/Cas9 system to functionally characterize the RBM24 RRM domain. Although cardiomyocytes (CMs) derived from two types of mutant lines were still able to induce a normal heartbeat, CMs derived from the ∆RRM-/- mutants exhibited a disorganized sarcomeric structure and abnormal mitochondrial morphology. In contrast, the ∆Exon2-/- mutants produced a well-organized sarcomeric structure, with a normal CM size and mitochondrial structure. Considered together, the data presented herein reveal that the RBM24 RRM domain is essential for ensuring a normal sarcomeric structure in hESC-derived CMs. These findings not only represent some evidence of the importance of the RBM24 RRM domain, they also suggest that RBM24 may regulate mitochondrial functions in human CMs. Future experiments will involve the application of RNA sequencing to further characterize the molecular mechanism underlying the effects of the RRM domain on sarcomerogenesis.

並列關鍵字

human pluripotent stem cell ； RNA-binding motif protein 24 ； RRM domain ； cardiomyocyte ； sarcomerogenesis ； cardiac differentiation ； CRISPR/Cas9 system

參考文獻

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS and Jones JM. Embryonic stem cell lines derived from human blastocysts. Science (New York, NY). 1998;282:1145-7.

2. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K and Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861-72.

3. Chambers SM, Qi Y, Mica Y, Lee G, Zhang X-J, Niu L, Bilsland J, Cao L, Stevens E, Whiting P, Shi S-H and Studer L. Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors. Nature Biotechnology. 2012;30:715.

4. Lian X, Zhang J, Azarin SM, Zhu K, Hazeltine LB, Bao X, Hsiao C, Kamp TJ and Palecek SP. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions. Nature protocols. 2013;8:162-75.

5. Mathapati S, Siller R, Impellizzeri AA, Lycke M, Vegheim K, Almaas R and Sullivan GJ. Small-Molecule-Directed Hepatocyte-Like Cell Differentiation of Human Pluripotent Stem Cells. Current protocols in stem cell biology. 2016;38:1g.6.1-1g.6.18.